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Summary 
The ob gene product, leptin, is an important circulating 
signal for the regulation of body weight. To identify 
high affinity leptin-binding sites, we generated a series 
of leptin-alkaline phosphatase (AP) fusion proteins as 
well as [i251]leptin. After a binding survey of cell lines 
and tissues, we identified leptin-binding sites in the 
mouse choroid plexus. A cDNA expression library was 
prepared from mouse choroid plexus and screened 
with a leptin-AP fusion protein to identify a leptin re- 
ceptor (OB-R). OB-R is a single membrane-spanning 
receptor most related to the gp130 signal-transducing 
component of the IL-6 receptor, the G-CSF receptor, 
and the LIF receptor. OB-R mRNA is expressed not 
only in choroid plexus, but also in several other tis- 
sues, including hypothalamus. Genetic mapping of the 
gene encoding OB-R shows that it is within the 5.1 CM 
interval of mouse chromosome 4 that contains the db 
locus. 
Introduction 
The recently cloned mouse obesity (oh) gene appears to 
encode an adipose tissue-derived signaling factor for 
body weight homeostasis (Zhang et al., 1994). Mice that 
are homozygous for mutations in this gene exhibit a pro- 
found obesity resulting from defects in energy expendi- 
ture, food intake, and nutrient partitioning (reviewed by 
Bray and York, 1979). Several recent studies have shown 
that recombinant OB protein (leptin) purified from Esche- 
richia coli can correct the obesity related phenotypes in 
ob/ob mice when exogenously administered (Campfield 
etal., 1995; Pelleymounteretal., 1995; Halaasetal., 1995; 
Stephens et al., 1995). Weight-reducing effects of recom- 
binant leptin were also observed in normal mice and mice 
with diet-induced obesity. Although the target tissues that 
mediate the effects of leptin have not yet been defined, 
the work of Campfield et al. (1995) and Stephens et al. 
(1995) demonstrate that leptin introduced into the lateral 
or third brain ventricle is effective at low doses, arguing 
for a direct central affect of the leptin molecule. 
Another well-characterized recessive obesity mutation, 
diabetes (db), also results in profound and early onset 
obesity (reviewed by Bray and York, 1979). Mice homozy- 
gous for the db mutation exhibit an obesity phenotype 
nearly identical to the phenotype of ob/ob mice (Coleman, 
1978). Parabiosis studies with ob/ob and db/db mice indi- 
cate that db/db mice may be defective in reception of the 
ob gene product signal (Coleman, 1973). These data have 
led to speculation that the db gene may encode the recep- 
tor for leptin, although the available data would also be 
consistent with db encoding a component of the leptin 
signal transduction pathway. 
Recent studies have suggested that obese humans and 
rodents (other than ob/ob mice) are not defective in their 
ability to produce leptin mRNA or protein and generally 
produce higher levels than lean individuals (Maffei et al., 
1995; Considineet al., 1995; Lonnqvist et al., 1995; Hamil- 
ton et al., 1995). These data suggest that resistance to 
normal or elevated levels of leptin may be more important 
than inadequate leptin production in human obesity. We 
have therefore begun a characterization of the mechanism 
of leptin signal reception. As a first step toward this goal, 
we have identified and cloned a high affinity receptor for 
the leptin molecule. 
Results 
Localization of Leptin-Binding Sites 
To search for the leptin receptor, we generated both puri- 
fied [1251]leptin and a series of leptin-alkaline phosphatase 
(AP) fusion proteins. To generate the leptin-AP fusion pro- 
teins, cDNAs encoding the mouse and human leptin pro- 
teins were inserted into the expression vectors APtag-2 
and APtag-3(see Experimental Procedures). Insertion into 
the expression vector APtag-2 resulted in fusion proteins 
with leptin at the N-terminus and placental AP at the 
C-terminus (OB-AP). Insertion into the vector APtag-3 re- 
sulted in fusion proteins with AP at the N-terminus fused 
to the predicted mature form of the leptin protein at the 
C-terminus (AP-OB) (Figure 1A). Figure 1B shows that 
both murine AP-OB and OB-AP are secreted proteins 
and that each is produced at the predicted molecular mass 
of approximately 81 kDa. 
After a search of mammalian cell lines and tissues, re- 
producible binding of the AP-OB fusion proteins and 
[‘251]leptin was observed in the mouse choroid plexus. For 
the [1251]leptin studies, coronal brain sections were taken 
and tissue slices incubated with 0.5 nM [1251]leptin. Tissues 
were then washed and exposed to film. Figure 2 shows 
strong [‘251]leptin binding to the choroid plexus in both the 
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Figure 1. Leptin-AP Fusion Proteins 
(A) The leptin-AP fusion proteins are illustrated: mob (murine leptin 
segment of fusion protein), hob (human leptin segment of fusion pro- 
tein), AP (alkaline phosphatase segment of fusion protein). 
(B) Expression of mouse OB-AP and AP-OB in the supernatants of 
transiently transfected COS7 cells. Supernatants were immunoprecip- 
itated with a monoclonal antibody against human placental AP, sepa- 
rated on a 10% polyacrylamide gel, and stained with Coomasie blue. 
Lane 1, markers; lane 2, medium from cells transfected with unfused 
AP expression vector; lane 3, medium from mock-transfected cells; 
lane 4, medium from cells transfected with AP-08 expression vector; 
lane 5, medium from cells transfected with OB-AP expression vector. 
CP 
lateral and third brain ventricles, which is blocked by the 
inclusion of an excess of cold leptin. For the AP-OB fusion 
protein studies, adult mouse brains were quartered and 
tested for bound AP activity of the fusion protein using 
standard histological techniques. Staining of the choroid 
plexus within the ventricles was observed with the mouse 
AP-OB fusion protein while no staining was observed in 
surrounding brain tissues. Similar staining was not seen 
in controls with unfused AP or when an excess of unfused 
leptin was included to compete for binding of the AP- 
OB fusion protein (data not shown). These observations 
indicated that leptin, even when fused to the AP molecule, 
was active for receptor binding. 
Expression Cloning of a Leptin Receptor 
from Mouse Choroid Plexus 
The strong leptin binding observed in the mouse choroid 
plexus in both the [1z5i]leptin and AP-OB in situ assays 
suggested that a leptin receptor is expressed in this tissue. 
To clone a receptor cDNA, we dissected the choroid 
plexus from 300 mice and used the isolated RNA to con- 
struct a cDNA expression library. The library was pro- 
duced as pools of 150 clones, and a mixture of eight pools 
was used in each transfection (1200 clones/transfection). 
Our earlier choroid plexus binding assays suggested that 
the murine AP-OB fusion protein gave a superior ratio of 
foreground to background signal when compared with the 
[‘251]leptin molecule. We therefore chose to screen the li- 
brary with the murine AP-OB protein. Pooled DNA was 
transiently transfected into COS7 cells, which were then 
incubated with supernatants containing the murine AP- 
OB fusion protein, washed, and stained for AP activity in 
Cl? 
Figure 2. Binding of [9]Leptin to Mouse Brain Sections 
Autoradiographic imagesof murine [‘ZSl]leptin binding to brain sectionsof C57BUSJ mice. (Top) Total binding (0.5 nM [‘251]leptin). (Bottom) Nonspecific 
binding (0.5 nM [1251]leptin plus 100 nM unlabeled murine leptin). CP, choroid plexus. Similar data was observed in db/db mice (original allele) 
(see Discussion). 
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situ. After screening 632 pools, we identified ten indepen- 
dent positive pools, all of which were successfully broken 
down to subpools of 150 clones each. One positive sub- 
pool was further subdivided until a single clone encoding 
a leptin-binding activity was identified. 
Nucleotide sequencing of the entire 5.1 kb cDNA insert 
revealed a single long open reading frame predicted to 
encode a protein of 894 amino acids. The polypeptide 
shown in Figure 3 is a novel single membrane-spanning 
receptor that we have named 06-R. The OB-R sequence 
begins with a methionine in a DNA sequence context, con- 
sistent with a translation initiation site, followed by a typical 
hydrophobic signal sequence for peptide secretion. The 
predicted mature extracellular domain is 816 amino acids 
long. The extracellular domain of OB-R shows many fea- 
tures of the class I cytokine receptor family (reviewed by 
Heldin, 1995) and is most closely related to the gp130 
signal-transducing component of the interleukin6 (IL-6) 
receptor (Taga et al., 1989), the granulocyte colony- 
stimulating factor (G-CSF) receptor (Fukunaga et al., 
1990a; Larsen et al., 1990) and the leukemia inhibitory 
factor (LIF) receptor (Gearing et al., 1991). An alignment 
between the extracellular domains of OB-R and gp130 is 
shown in Figure 4. Although the overall amino acid se- 
quence identity between these two molecules is low 
(24%) the characteristically conserved cysteine residues, 
the Trp-Ser-X-Trp-Ser motif, and conservation of other res- 
idues within this group of proteins are clearly evident (re- 
viewed by Kishimoto et al., 1994). The extracellular do- 
main is followed by a predicted transmembrane domain 
(23 amino acids) and a short cytoplasmic domain (34 
amino acids). Amino acids 5-24 of the OB-R cytoplasmic 
domain show 47% identity to membrane proximal se- 
quences of the intracellular domain of the LIF receptor 
and contain a box 1 JAK interaction sequence (Narazaki 
et al., 1994). 
Although a short cytoplasmic domain is characteristic 
of several class I cytokine receptor polypeptides (reviewed 
by Kishimoto et al., 1994), the three receptors to which 
OB-R shows the strongest homology all have long cyto- 
plasmic domains important in intracellular signaling. This 
opened the possibility that the OB-R clone we had isolated 
was chimeric or encoded a rare aberrantly spliced form not 
representing the major form expressed within the choroid 
plexus. We therefore selected eight clones that were inde- 
pendently identified in our library screen and amplified 
each of these (in subpools of 150 clones each) by polymer- 
ase chain reaction (PCR) with primers made to sequences 
3’of the stop codon and verified that all eight clones con- 
tained these same 3’untranslated sequences. In addition, 
the C-terminus of five independently isolated clones was 
sequenced, and all were shown to have the same stop 
codon. Finally, reverse transcription-PCR (RT-PCR) with 
total RNA from choroid plexus isolated from a different 
Figure 3. Deduced Amino Acid Sequence of the 06-R Protein 
Probable secretion signal sequence, transmembrane domain, and two 
Trp-Ser-X-Trp-Ser motifs are underlined. A conserved CyGrp motif 
is Indicated by asterisks. 
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Figure 4. Alignment of the Extracellular Do- 
mains of OS-R and Human gp130 
Identical residues (closed) and conservative 
changes (stippled) are indicated around the 
corresponding amino acids. Conservative 
changes are indicated as defined by FASTA. 
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mouse strain (C57BLIKsJ) than that from which the cDNA 
library was derived, generated an identical PCR product 
containing a stop codon in the same location. These data 
indicated that the isolated clone is neither a chimera nor 
a rare aberrant splice event, but rather is likely to be the 
predominant form of this receptor in the choroid plexus. 
Binding Characteristics of 08-R 
A quantitative analysis of the binding of the AP fusion 
proteins is shown in Figure 5. After transient transfection 
of the 06-R clone into COS cells, strong binding of 1 nM 
murine AP-06 is detected (relative to mock-transfected 
COS cells or OB-R-transfected COS cells incubated with 
unfused AP) (Figure 5A). This binding is nearly completely 
inhibited by 100 nM untagged recombinant mouse or hu- 
man leptin protein, demonstrating that this receptor can 
bind native leptin. A fusion between AP and human leptin 
also binds mouse OB-R with high affinity, as does a fusion 
protein with mouse leptin at the N-terminus and AP at the 
C-terminus (OB-AP). Scatchard analysis of the binding 
of mouse AP-OB (Figure 58) produced a value for the 
dissociation constant (KD) of 0.7 x 1 Omg M. Similar specific 
high affinity binding was observed with [1251]leptin (data 
not shown). 
Expression Profile of OB-R mRNA 
As a first step in understanding the tissue distribution of 
OB-R, we examined the expression of its mRNA in various 
tissues. Figure 6A shows a poly(A)+ mRNA Northern blot 
analysis of several mouse tissues. In most tissues, the 
OB-R mRNA appears as a single band slightly larger than 
5 kb, suggesting that our 5.1 kb cloned cDNA is near full 
length. Of the tissues present on this blot, the highest 
levels of expression are seen in lung and kidney. Lower 
levels of expression are seen in several other tissues, in- 
cluding total brain. No expression was detected in testes. 
RT-PCR amplification of the OB-R mRNA from total RNA 
confirmed the presence of this transcript in choroid plexus 
and also demonstrated its presence in hypothalamus (Fig- 
ure 6B). 
Genetic Mapping of the Gene Encoding O&R (Obr) 
Primers were designed from the coding sequence of the 
OB-R cDNA. These primers amplified a 192 bp fragment 
from C57BU6J genomic DNA and a 195 bp fragment from 
the wild-derived Mus spretus strain SPRET/Ei (data not 
shown). The genetic segregation of the M. spretus Obr 
allele was followed in 183 backcross progeny of the cross 
(C57BL16J x M. spretus)Fl females x C57BU6J males 
by both single strand conformation polymorphism gel elec- 
trophoresis and nondenaturing gel electrophoresisfor size 
determination. The segregation pattern of the M. spretus 
allele was compared with the segregation pattern of 226 
other genetic loci that have been mapped in this backcross 
panel. By minimizing the number of multiple crossovers 
between Obr and other markers, it was determined that 
Obr maps to murine chromosome 4, approximately 2.2 + 
1.1 CM distal to the marker D4Mit9 and 4.6 + 1.6 CM 
proximal of the marker D4Mit46. The genetic map position 
of Obr was further refined by mapping additional genetic 
markers. Obr maps 0.6 f 0.6 CM distal from D4Mit255 
and 0.6 + 0.6 CM proximal to D4Mif755 (Figure 7). 
The db mutation originally arose on the C57BUKsJ in- 
bred mouse strain and was mapped to mouse chromo- 
some 4 (Hummel et al., 1966). The db mutation has subse- 
quently been transferred to other genetic backgrounds to 
form congenic strains. By typing animals of the congenic 
strain C57BL/6J-m db for multiple anonymous DNA mark- 
ers (Dietrich et al., 1994; Copeland et al., 1993) it was 
possible to define the genetic interval within which the db 
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Figure 5. Binding of Leptrn and AP Fusions to OB-R 
(A) COS7 cells transfected with the OB-R cDNA were treated with 
various AP or leptin-AP fusion proteins at 1 nM (diluted in Dulbecco’s 
modified Eagle’s medium plus 10% fetal bovine serum). Columns show 
the average of two binding determinations and error bars show the 
difference between the two. Bar 1, unfused AP; bar 2, AP-OB (mouse); 
bar 3, AP-OB (mouse) plus 100 nM mouse leptin; bar 4, AP-OB 
(mouse) plus 100 nM human leptin; bar 5, AP-OB (human); bar 6, OB- 
AP (mouse); bar 7. AP-08 (mouse) incubated with mock transfected 
(vector-no insert) COS7 cells. 
(B) Binding isotherm and Scatchard analysis of the interaction of AP- 
OB and OB-R. COS7 cells lransfected with the OB-R cDNA were incu- 
bated with various concentrations of the AP-08 (mouse) fusion pro- 
tein. Scatchard transformahon is shown as an Inset. 
gene must reside on mouse chromosome 4. It lies between 
the proximal marker D4Mit255 and the distal marker 
D4Mit37 (Figure 7). This is an approximately 5.1 CM inter- 
val. The map position of Obr, 0.6 ? 0.6 CM distal from 
D4Mit255, is within the db minimal interval. 
Cloning of a Human OB-R Homolog 
To identify a human 06-R homolog and address the extent 
of sequence conservation, we isolated and sequenced a 
cDNA clone hybridizing to OB-R from a human infant total 
brain library. The amino acid sequences from mouse and 
human were highly homologous throughout the length of 
2.4- 
1.35- 
Figure 6. Tissue Distribution of the OB-R mRNA 
(A) Northern blot of poly(A)+ mRNA (2 ugllane) from various mouse 
tissues (Clontech) probed with labeled DNA amplified from sequences 
encoding the OB-R extracellular domain. Hybridizations were done in 
Rapid-hyb buffer (Amersham) at 65% following the instructions of the 
manufacturer. 
(B) RT-PCRs were performed on 1 Kg of total RNA isolated from mouse 
choroid plexus or hypothalamus. Tissues were isolated from db/db 
mice(C57BUKsJ background)or(+/+) littermatecontrolsasindicated. 
First-strand cDNA, prepared using random hexamers, was PCR ampll- 
fied using primers derived from sequences encoding the OB-R extra- 
cellular domain or glyceraldehyde 3-phosphate dehydrogenase 
(GBPDH) control primers. No bands were detected from the amplifica- 
tion of mock reverse-transcribed total RNA controls run in parallel (data 
not shown). 
mouse 06-R (Figure 8). in fact, the deduced amino acid 
sequence identity between our mouse and human clones 
(78%) is the same or greater than that seen when compar- 
ing the mouse and human forms of gp130 (Saito et al., 
1992) the LIF receptor (Gough et al., 1988) and the 
G-CSF receptor (Fukunaga et al., 1990b). Interestingly, 
the human cDNA encodes a protein with a much longer 
intracellular domain than mouse 06-R. Although the 
mouse and human intracellular domains are highly con- 
served up to the final five residues of mouse OB-R, the 
human intracellular domain continues to a length similar 
to that of gp130. The nucleotide sequences of the mouse 
and human clones are also very similar throughout the 
coding region of mouse 06-R, but then diverge completely 
near the mouse 06-R stop codon, suggestive of an alter- 
native splice. 
Discussion 
The cloning of the ob gene and the recent initial character- 
ization of its gene product (08 protein or leptin) have dra- 
matically illustrated the importance of this protein in the 
regulation of energy balance. Leptin is an adipose tissue- 
derived circulating hormone that, when absent, results in 
profound obesity (ob/ob mice) and, when exogenously 
supplied, can reduce food intake and body weight in a 
variety of rodent models (Zhang et al., 1994; Campfield 
etal., 1995; Pelleymounteret al., 1995; Halaaset al., 1995; 
Stephens et al., 1995). Several theories have been pro- 
posed in which a circulating leptin protein exerts its pro- 
found effects on appetite and body weight via direct bind- 
ing to receptors in the central nervous system. Evidence 
in support of this model includes the observations that 
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leptin injected directly into the brain ventricles reduced 
appetite and body weight (Campfield et al., 1995; Ste- 
phens et al., 1995) and that lesions of the hypothalamus 
can result in an obesity resembling the ob phenotype (De- 
bons et al., 1977). The mechanism by which leptin enters 
the central nervous system has not been addressed. 
We have identified and cloned a leptin-binding receptor, 
OB-R, that is expressed in the mouse choroid plexus. 
OB-R resembles aclass I cytokine receptor, and its mRNA 
expression pattern suggests it may be expressed through 
various tissues, including the hypothalamus. We have ge- 
netically mapped the gene encoding OB-R to the 5 CM 
interval that contains the db locus. db/db mice have a 
phenotype nearly identical to ob/ob mice (Coleman, 1978) 
and have recently been shown to be resistant to recombi- 
nant leptin (Campfield et al., 1995; Pelleymounter et al., 
1995; Halaas et al., 1995; Stephens et al., 1995). This, as 
well as earlier parabiosis experiments (Coleman, 1973), 
has lead to speculation that db encodes the receptor for 
leptin. However, the available data do not distinguish 
among the db gene encoding a receptor-binding chain, a 
signaling chain, or an intracellular component of the leptin 
signaling pathway. Whether or not the receptor we have 
cloned is encoded by the db gene has not been resolved. 
The map location of Obr within the db minimum interval 
(encompassing only l/300 of the mouse genome), offers 
the possibility that OB-R is encoded by the db locus. How- 
ever, we have found that both [1251]leptin and the AP-OB 
fusion protein bind nearly as well to the choroid plexus of 
db/db mice (original allele) as to wild-type mice (data not 
shown). Consistent with this, we have not identified a mu- 
tation within the coding sequence of the mRNA species 
expressed in the choroid plexus of these mice. Therefore, 
if the db gene encodes OB-R, it is likely that the mutation 
in this allele will be found in a different splice variant of 
mouse OB-R, such as a splice form similar to the human 
brain OB-R homolog we have identified. 
Another possibility is that OB-R is not encoded by the 
db gene and serves a different function than primary sig- 
naling. Within the choroid plexus, there are multiple possi- 
bilities for how OB-R might function. One is that it serves 
a transport function, moving leptin from the peripheral cir- 
culation into the central nervous system. The choroid 
plexus is known to be largely responsible for the genera- 
tion of the cerebrospinal fluid and is one of the barriers 
between the blood and the cerebrospinal fluid (reviewed 
by Spector and Johanson, 1989). Another possibility is 
that 06-R serves a clearance function, as has been postu- 
lated for the high levels of insulin receptor expressed in 
the choroid plexus (reviewed by Schwartz et al., 1992). A 
third possibility is that binding of leptin to choroid plexus 
membranes leads to the activation of afferent neural inputs 
to the network that regulates feeding behavior and energy 
balance. 
Whether the OB-R polypeptide itself is capable of initiat- 
ing intracellular signal transduction requires further inves- 
tigation. The sequence of the OB-R protein predicts that 
it is a large single membrane-spanning receptor of the 
class I cytokine receptor family(reviewed by Heldin, 1995). 
If OB-R does participate in signaling complexes, its short 
intracellular domain suggests that it likely interacts with 
other signaling polypeptide chains. This mechanism has 
been established for several class I cytokines receptors 
with short intracellular domains (reviewed by Kishimoto 
et al., 1994). Another possibility is that, in some tissues, 
alternatively spliced forms of mouse OB-R exist with 
longer intracellular domains. Support for this hypothesis 
comes from our identification of a human OB-R homolog 
with a long intracellular domain. Furthermore, the class I 
cytokine receptors to which OB-R is most closely related 
are the gp130 signal-transducing component of the IL-6 
receptor (Taga et al., 1989), the G-CSF receptor (Fuku- 
naga et al., 1990a; Larsen et al., 1990), and the LIF recep- 
tor (Gearing et al., 1991), all of which have long intracellu- 
lar signaling domains. 
The tissue sites at which leptin initiates receptor- 
mediated signal transduction remain to be established. 
However, there is a large body of evidence supporting a 
role of the hypothalamus in energy balance (reviewed by 
Bray and York, 1979), suggesting that leptin binding to 
this site may be of pivotal importance. We have demon- 
strated the presence of OB-R RNA not only in the choroid 
plexus, but also in other tissues including hypothalamus. 
This raises the possibility that OB-R (or a splice variant) 
may participate directly in signal transduction within the 
hypothalamus. Further studies will be required to test this 
hypothesis and to address the importance of leptin binding 
to other sites in the brain and peripheral tissues. 
The cloning of a leptin receptor may have quite im- 
portant implications for our understanding and treatment 
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of body weight dysregulation. The recent observations that 
obese humans and obese mice (other than ob/ob) have 
high levels of leptin or leptin mRNA, relative to lean con- 
trols, suggest that the majority of obesity is likely to be a 
consequence of leptin resistance, rather than inadequate 
amounts of leptin itself (Maffei et al., 1995; Considine et 
al., 1995; Lonnqvist et al., 1995; Hamilton et al., 1995). The 
cloning of 08-R will allow for an examination of potential 
mutations within this molecule in obese humans and may 
further our understanding of the mechanisms of leptin re- 
sistance in human obesity. 
Experimental Procedures 
Reagents 
The recombinant murine leptin used in this study has been described 
previously (Campfield et al., 1995). The recombinant human leptin was 
purified from baculovirus supernatants with a monoclonal antibody 
column against human leptin and was judged by Coomassie blue stain- 
mg to be greater than 95% pure. The [1251]leptin was prepared by the 
lodogen method as described by the manufacturer (Pierce). 
Construction and Expression of AP Fusion Proteins 
To produce the mouse and human OB-AP and AP-OB fusion con- 
structs, cDNA sequences were amplified by PCR. For mouse and 
human OB-AP, sequences encoding the entire ob open reading frame 
and a small amount of 5’ untranslated sequence were amplified from 
the corresponding cDNAs. Restriction sites at the end of the amplifica- 
tion primers were cut with Hindlll and BamHl (mouse) and inserted 
Into the Hindlll-Bglll polylinker site of APtag-2 (Cheng et al., 1995) or 
with BamHl and Bglll (human) and inserted into the Bglll site of AP- 
tag-2. For mouse and human AP-OB fusion constructs, an AP fusion 
vector expressing an AP molecule with its own signal peptide was first 
generated (APtag-3) by replacing sequences between the Hindlll and 
Xhol sites of APtag2 with PCR-amplified sequences of secreted pla- 
cental AP. A Bglll site was placed so that fusions introduced into this 
site would be in-frame with the AP protein. The sequences encoding 
the predicted mature forms of mouse and human leptin were then 
PCR amplified from the corresponding cDNAs. Restriction sites at the 
end of the amplification primers were cut with BamHl and Bglll and 
Inserted into the Bglll site of APtag-3. 
Each plasmid was transiently transfected into COS7 cells (11.25 ng 
per 150 mm plate). Cells were grown to confluence, and then medium 
conditioned for a further 3 days was centrifuged, 0.45 pm filtered, and 
stored at 4°C with 20 mM HEPES (pH 7.0) and 0.05% sodium azide. 
Conditioned medium was tested and quantitated for AP activity in a 
96-well plate reader as described previously (Flanagan and Leder, 
1990) except that homoarginine was omitted from all assays. 
AP In Situ of Murine Choroid Plexus 
Quartered mouse brains or isolated choroid plexi were Incubated in 
tissue culture supernatants containing AP-OB fusion, OB-AP fusion, 
or various control supernatants for 75 min with gentle rotation at room 
temperature. Tissues were then treated as described previously 
(Cheng and Flanagan, 1994). 
Expression Library Construction and Screening 
Choroid plexi from 300 mice were isolated and frozen on dry ice. Total 
RNA was isolated from mouse choroid plexus using the guanidinium 
isothiocyanate-CsCI method of Chirgwin et al. (1979). After quantita- 
tion, the RNA was diluted to 1 mglml in water and incubated for 30 
mm at 37% with an equal volume of DNase solution (20 mM MgCI,, 
2 mM DTT. 0.1 U of DNase, 0.6 U of RNase inhibitor in Tris-EDTA) 
to remove contaminating DNA. The RNA was extracted with phenol- 
chloroform-isoamyl alcohol and ethanol precipitated. After quantita- 
Figure 8. Alignment of Mouse OB-R and a Human Homolog 
Amino acids that are identical between the two sequences are indi- 
cated by an asterisk. Abbreviations: mobr, mouse OB-R; hobr, human 
homolog. 
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tion at 260 nm, an aliquot was electrophoresed to check the integrity. 
Poly(A)’ RNA was isolated using an Oligotex-dT kit from Qiagen as 
described bythe manufacturer. Afterquantitation, the mRNAwasetha- 
nol precipitated and resuspended at 1 mglml in DEPC-treated water. 
cDNA was synthesized according to the method of Gubler and Hoff- 
man (1963) using a Life Technologies Superscript plasmid cDNA syn- 
thesis kit. The cDNA obtained was ligated into the Notl-Sall sites 
of the mammalian expression vector pMET7, a modified version of 
pME16S that utilizes the SRa promoter as described previously (Ta- 
kebe et al., 1986). Ligated DNA was EtOH precipitated and resus- 
pended in water at 25 nglul. DNA (1 nl) was transformed by electropora- 
tion per 40 ul of electrocompetent DHlOB E. coli cells in a 0.1 cm 
cuvette. Based on titers of the cDNA transformations, 96-well plates 
were inoculated with 150 cfu per well in 1 ml of LB-Amp. Cultures 
were grown 15-16 hr at 37OC with aeration. Prior to prepping, 100 ul 
of cell suspension was removed and added to 100 nl of 50% glycerol, 
mixed, and stored at -6OOC. DNA was prepared using the Promega 
Wizard miniprep system employing modifications for a 96-well format. 
DNA was quantitated by OD readings at 260 nm. 
To screen the library, DNA of each pool was transiently transfected 
into a 10 cm dish of COS cells with lipofectamine (GIBCO BRL). After 
46 hr. the cells, just at or before confluence, were washed once in 
Hanks balanced salt solution (HBHA) with 0.5 mglml BSA, 0.5% so- 
dium azide, 20 mM HEPES (pH 7.0), and then incubated in 5 nM 
murine AP-OB supernatant for 75 min at room temperature. Plates 
were then washed six times in HBHA, treated for 30 s with acetone- 
formaldehyde fixative (60% acetone, 3% formaldehyde, 20 mM 
HEPES [pH 7.01) and washed twice in HBHA. Plates were then incu- 
bated in 10 ml of HBS (150 mM NaCI, 20 mM HEPES [pH 7.01) in a 
single layer on a flat shelf in a 65’C oven for 100 min. Plates were 
then rinsed with AP buffer (100 mM Tris-HCI [pH 9.51, 100 mM NaCI, 
5 mM MgCI?) and stained for 0.5-l 2 hr in the same buffer containing 
0.17 mglml BCIP and 0.33 mglml NBT. Staining was monitored periodi- 
cally against a white background under a dissecting microscope. 
Quantitative Cell Surface Binding and lmmunoprecipitation 
Quantitative cell surface binding and immunoprecipitation were done 
essentially as described (Cheng and Flanagan, 1994). 
(‘*51]Leptin Binding to Brain Sections 
Mouse coronal brain sections were incubated for 90 min at 4OC with 
0.5 nM [1251]leptin in incubation medium (50 mM Tris-HCI, 0.2% BSA, 
0.1 mM phenylmethylsulfonylfluoride, 0.1 mM phenantroline [pH 7.51). 
Nonspecific binding was determined by incubation of adjacent sec- 
tions in the presence of the indicated amount of unlabeled leptin. After 
two washes with cold incubation medium, the sections were exposed 
to LKB ultrofilm for 2 weeks. 
Sequencing and Human cDNA Library Screening 
Sequencing and sequence assembly were performed as described 
previously (The International Polycystic Kidney Disease Consortium, 
1995). The human infant total brain library was obtained from Stra- 
tagene and screened as recommended by the manufacturer. 
Genetic Mapping 
The PCR amplification conditions for all markers, including the Obr 
fragment, were a hot start with 0.15 U of AmpliTaq, followed by 30 
cycles of 94“C for 40 s, 55’C for 50 s, 72OC for 30 s. The products 
were run on either a nondenaturing 6% polyacrylamide gel at 45 W 
at room temperature for 3 hr or on a 10% polyacrylamide single strand 
conformation polymorphism gel run at 20 W at 4°C for 2.5 hr. Both 
types of gel were stained, postelectrophoresis. with SYBR green I and 
scanned on an MD Fluorimager. 
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